For: | Wang W, Deng ZF, Wang JL, Zhang L, Bao L, Xu BH, Zhu H, Guo Y, Wen Z. Change of tumor-infiltrating lymphocyte of associating liver partition and portal vein ligation for staged hepatectomy for hepatocellular carcinoma. World J Gastrointest Surg 2022; 14(9): 1008-1025 [PMID: 36185571 DOI: 10.4240/wjgs.v14.i9.1008] |
---|---|
URL: | https://www.wjgnet.com/1948-9366/full/v14/i9/1008.htm |
Number | Citing Articles |
1 |
Lingzhen Hu, Zongren Wang, Yang Liao, Xiaomeng Jiang, Huojun Lian, Zhuoying Lin. Tumor-infiltrating T-Lymphocyte immunity-related immune tolerance and anti–programmed cell death protein 1/ligand of programmed cell death protein 1 therapy for advanced hepatocellular carcinoma. Oncology and Translational Medicine 2024; 10(4): 162 doi: 10.1097/ot9.0000000000000041
|
2 |
Victor Lopez-Lopez, Carlos Martínez-Caceres, Paula Gomez-Valles, Juan Cruz, Albert Caballero-Illanes, Roberto Brusadin, Asuncion López-Conesa, María Pérez, Kohei Miura, Jesús de la Peña-Moral, Ricardo Robles-Campos. Impact of rapid hypertrophy of tourniquet associating liver partition and portal vein ligation in the tumor progression pathways compared to two stage hepatectomy in patients with colorectal liver metastases. HPB 2023; 25(10): 1235 doi: 10.1016/j.hpb.2023.06.005
|